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Abstract
Recent epidemiologic, genetic, and molecular studies suggest infection and inflammation initiate certain cancers, including
those of the prostate. The American Cancer Society, estimates that approximately 20% of all worldwide cancers are caused
by infection. Mycoplasma, a genus of bacteria that lack a cell wall, are among the few prokaryotes that can grow in close
relationship with mammalian cells, often without any apparent pathology, for extended periods of time. In this study, the
capacity of Mycoplasma genitalium, a prevalent sexually transmitted infection, and Mycoplasma hyorhinis, a mycoplasma
found at unusually high frequency among patients with AIDS, to induce a malignant phenotype in benign human prostate
cells (BPH-1) was evaluated using a series of in vitro and in vivo assays. After 19 weeks of culture, infected BPH-1 cells
achieved anchorage-independent growth and increased migration and invasion. Malignant transformation of infected BPH-
1 cells was confirmed by the formation of xenograft tumors in athymic mice. Associated with these changes was an increase
in karyotypic entropy, evident by the accumulation of chromosomal aberrations and polysomy. This is the first report
describing the capacity of M. genitalium or M. hyorhinis infection to lead to the malignant transformation of benign human
epithelial cells and may serve as a model to further study the relationship between prostatitis and prostatic carcinogenesis.
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Introduction
Mycoplasma, a class of bacteria that lack a cell wall, are among
the few prokaryotes that can grow in close relationship with
mammalian cells, often without any apparent pathology, for
extended periods of time [1]. Due to the fastidious nature of
mycoplasma, it is often difficult to isolate the organism from
human specimens or the study implements a molecular amplifi-
cation approach for its detection [2]. As a consequence, many
mycoplasmal infections may go unreported. Nevertheless, M.
genitalium has been identified as the cause of non-gonococcal
urethritis in approximately 15–22% of symptomatic men [3–5]. In
fact, in a sexually transmitted disease clinic in a major US
metropolitan area, the presence of M. genitalium was more
prevalent than Neisseria gonorrhea but less prevalent than Chlamydia
trachomatis [6]. Several studies have also linked M. genitalium with
chronic persistent prostatitis [7,8].
Recent epidemiologic, genetic, and molecular studies suggest
that infection and inflammation initiate certain cancers, including
prostate cancer [9–12]. According to the American Cancer
Society, approximately 20% of all worldwide cancers are caused
by infectious agents [13]. Infectious agents may directly induce
tumorigenesis through viral or bacterial protein products that have
oncogenic effects or indirectly through a local chronic progressive
inflammatory response [14,15]. Although the mechanisms by
which viruses initiate carcinogenesis is being elucidated [12], there
is a paucity of information regarding the contributory role of
bacterial infection in prostate cancer.
Previously, our laboratory has provided evidence of a
correlation between mycoplasma protein activity and malignant
potential. Specifically, we demonstrated that recombinant M.
hyorhinis protein p37 enhanced the invasiveness of two prostate
carcinoma and two melanoma cell lines in a dose-dependent
manner in vitro. These effects could be completely blocked with a
neutralizing antibody to p37 [16]. In a separate study, recombi-
nant M. hyorhinis p37 induced a more malignant phenotype in
prostate cancer cells PC-3 and DU145 as demonstrated by
induction of anaplasia and increased migration. Furthermore,
these cells showed differential expression of genes involved in cell
cycle, signal transduction and metabolism [17]. Taken together,
these studies support an association between mycoplasma infection
and aggressive cellular phenotype.
In the current study, we investigated the in vitro and in vivo effects
of chronic mycoplasmal infection on a benign human prostate cell
PLoS ONE | www.plosone.org 1 September 2009 | Volume 4 | Issue 9 | e6872line, BPH-1. We demonstrated significant phenotypic and
karyotypic changes that ultimately resulted in the malignant
transformation of benign BPH-1 cells.
Results
Experimental plan
BPH-1 cells were infected with M. genitalium or M. hyorhinis and
maintained in continuous culture for 20 weeks. Uninfected BPH-1
cells were cultured in parallel for comparison. At weeks 4, 7, 11, 15
and 19, mycoplasmal infection status was confirmed by PCR, and
a series of in vitro assays were performed (Figure 1). At weeks 7 and
19, infected and uninfected BPH-1 cells were inoculated into
athymic mice to assess tumorigenicity (Figure 1).
In vitro migration and invasion assays
We have previously published that in a dose-dependent manner,
p37 increases tumor cell migration and invasion in both PC-3 and
DU145 cancer cells [16,17]. To investigate whether this
phenomenon can be replicated with mycoplasma, we evaluated
the migratory and invasive potential of BPH-1, with or without the
presence of M. hyorhinis or M. genitalium, over the course of the 19
weeks of infection. As shown in Figure 2, a statistically significant
increase in migration and invasion was evident for BPH-1 cells
infected with M. hyorhinis and with M. genitalium (p,0.05) 19 weeks
after initial infection. This response was not evident at 7 weeks
after inoculation (Figure 2).
Anchorage Independent Growth
Uninfected and mycoplasmal infected BPH-1 cells in culture
from passages 7 and 19 were investigated for their capacity to form
anchorage-independent colonies in soft agar, a property associated
with malignant cell transformation. In parallel with the capacity of
cells in culture to migrate and invade, M. hyorhinis or M. genitalium
infected BPH-1 cultures gained the capacity to grow and form
colonies in soft agar at 19 weeks after infection (Figure 3). BPH-1
cells infected for only 7 weeks did not exhibit anchorage
independent growth. Uninfected BPH-1 cells from week 19 of
parallel cutlure were also unable to form colonies in soft agar
(Figure 3). The anchorage-independent human prostate cancer cell
PC-3, served as a positive control in these experiments (Figure 3).
Prolonged mycoplasma infection induces karyotypic
entropy in BPH-1 cells
The accumulation of chromosomal abnormalities that affect the
balance of critical genes involved in the control of cellular growth,
differentiation and survival is thought to drive the multistep process of
cancer development and progression. To investigate whether gross
structural chromosomal changes were associated with the phenotypic
changes observed in the BPH-1 prostate cell line model, we performed
a detailed molecular cytogenetic evaluation of BPH-1 cells subjected to
19-week mycoplasma infection and compared the karyotype with
uninfected cells. Using spectral karyotyping (SKY), a multicolor
technique that enables the visualization of all 48 human chromosomes
through fluorescent image analysis [18,19], we were able to define the
karyotype of BPH-1 cells and resolve the identity of marker
chromosomes. Metaphase chromosome preparations were made from
parallel, exponentially growing cultures (untreated and mycoplasma-
infected). Parental BPH-1 cells (Figure 4A) had a modal number of 53
chromosomes (average number of total chromosomes) with relatively
few aberrations, including 2 marker chromosomes t(4;11;20;9) and
t(10;12;16). The parental BPH-1 karyotype was: 53, XXY,+3,
del(4q),+t(4;11;20;9),6,+t(7;15),+i(9or18),t(10;15),+11,+add(11p),13,
+t(8;20;14),+t(10;12;16),+19,+20,-21,-22. Conversely, markedly altered
karyotypes were observed after prolnged infection with mycoplasma.
The representative metaphase spread shown in Figure 4B depicts the
variety of rearrangements observed in the M. hyorhinisinfected BPH-1
cells. These cells retained the 2 major marker chromosomes,
t(4;11;20;9) and t(10;12;16), but also gained random marker
chromosomes (for example, t(9;X;14). However, the major difference
observed in the infected cells was the accumulation of multiple copies
of apparently normal chromosomes, i.e., increased copy number of
chromosomes. The modal number was 63 (over 53 for uninfected
cells described above). Trisomy of chromosomes 1, 2, 6, 7, 15–18,
and 21 was typical. Loss of chromosome 13 was also observed in
multiple metaphases (Figure 4B). The full karyotype for M. hyorhinis
infected BPH-1 cells was as follows (most consistent changes in bold):
53-65, XXY, +1,+2,+3,+t(4;20;9),del(4),+6,+7,+t(7;15),+i(9),+9,+t(10;
15),+11,add(11),+t(5;11),13x2,+t(14;5),+5,+16,+t(10;12;16),+17,
+18,+19,+20,+21,-22x2,+t(9;X;14). In similar fashion, BPH-1 cells
infected with M. genitalium showed multiple chromosomal aberrations.
The karyotype for these cells was (most consistent changes in bold): 61-
65,XY,+X,+1,+2,+3,+der(4)t(4;11;20;18),+8,+9,der(10;22)t(10;22),
+11,+11withins,+der(12)t(10;12;16),+der(14)t(14;),+der(14)t(14;20;8),
+15,+16,+17,+i(18),t(16;18),+19,+20,+21,-22 (data not shown). Al-
though there were many differences indetail, the overall accumulation of
aberrations caused by infection by the two mycoplasma species was
similar, and the major change observed was increased polysomy, i.e. the
addition of extra, complete chromosomes.
Figure 1. Experimental plan. Benign human prostate BPH-1 cells
were infected with the mycoplsmas M. genitalium or M. hyorhinis and
maintained in continuous tissue culture for 20 weeks. Uninfected BPH-1
cells were cultured in parallel for comparison. At weeks 4, 7, 11, 15 and
19, mycoplasmal infection status was confirmed by PCR, and a series of
in vitro assays were performed. In vitro assays included anchorage-
independent growth in soft agar, and migration and invasions assays
using modified Boyden chambers. At weeks 7 and 19, infected and
uninfected BPH-1 cells were inoculated into athymic mice to assess
tumorigenicity
doi:10.1371/journal.pone.0006872.g001
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PLoS ONE | www.plosone.org 2 September 2009 | Volume 4 | Issue 9 | e6872Figure 2. In vitro invasion and migration. BPH-1 cells with and without M. genitalium (Mg) or M. hyorhinis (Mh) infection were tested for
migration (A) and invasion (B) potential at weeks 7 and 19 post-infection. Both M. genitalium and M. hyorhinis infected BPH-1 cells had increased
migration and invasion rates at week 19. Data presented are means of triplicates, and the error bars represent the standard error of the mean. *,
p,0.05 versus no mycoplasma control (M-).
doi:10.1371/journal.pone.0006872.g002
Figure 3. Anchorage-independent growth. BPH-1 cells infected with M. genitalium (Mg) or M. hyorhinis (Mh) were tested for the ability to grow
in soft agar. Persistent infection for 19 weeks with either mycoplasma induced anchorage-independent growth of BPH-1 cells. The PC-3 prostate
cancer cell line was used as a positive control. (10 micrometer scale bar =2 mm)
doi:10.1371/journal.pone.0006872.g003
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We determined whether mycoplasmal infection could induce
the gold standard of malignant transformation, tumorigenicity.
Uninfected BPH-1 cells, or BPH-1 infected with M. hyorhinis or M.
genitalium from passage 7 and passage 19 were inoculated
subcutaneously in male nude mice. Tumors were monitored twice
weekly for 15 weeks and recorded. Only subcutaneous growths
.5 mm in diameter were considered to be a tumor. No tumors
were evident in any animals inoculated with BPH-1 cells isolated
from passage 7. However, infected cells from passage 19 did
initiate tumors. Three tumors (43%) developed after M. genitalium
infected cell inoculation (median tumor size 190620 mm
3), and
five tumors (63%) developed from M. hyorhinis infected cell
inoculations (median tumor size 87610 mm
3). No tumors
developed at sites inoculated with uninfected BPH-1 cells, only
small nodules (1–3 mm diameter) were evident in some animals
(Table 1).
To confirm the composition of tumors/nodules, xenograft
tissues were resected, stained with hematoxylin and eosin, and
histologically examined. The uninfected BPH-1 cells present in
small nodules had uniform round nuclei and a mosaic pattern of
growth without atypia or infiltration. BPH-1 cells infected with M.
Figure 4. Cytogenetic analysis of mycoplasma infected BPH-1 cells. Metaphase chromosomal complement was revealed by spectral
karyotyping (SKY) and counter-staining with DAPI. Representative metaphase cells after SKY classification are shown. A, uninfected BPH-1 cells. B,
BPH-1 cells after 19 weeks M. hyorhinis infection. Composite for each chromosome shows, left to right, inverted DAPI-stained image, and spectral
imaging color representation. Chromosome number is shown below image groupings, numbers alongside the derivative chromosomes indicate the
origin of the translocated material. M. hyorhinis exposed BPH-1 cells were noted to harbor trisomy of chromosomes 1, 2, 6, 7, 15–18, and 21, in
addition to loss of chromosome 13.
doi:10.1371/journal.pone.0006872.g004
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nuclear atypia and active mitosis. Furthermore, invasion of these
cells into skeletal muscle was observed. BPH-1 cells infected with
M. hyrohinis grew in solid nests with minimal intervening stroma
and had nuclear atypia and active mitosis. Tumors generated by
mycoplasma infection in BPH-1 cells did not have the typical
glandular appearance of adenocarcinoma but instead had more
features of squamous differentiation (Figure 5). Previous studies
have documented the inability of unmanipulated BPH-1 cells to
grow as xenograft tumors in athymic mice [20].
To further investigate the composition of BPH-1 tumors,
immunohistochemical analyses were used to monitor the expres-
Table 1. Growth of BPH-1 xenograft tumors.
Culture 7 week 19 week
Tumorigenicity in mice (%) Tumorigenicity in mice (%)
Uninfected 0/7 (0) 0/7 (0)
M. genitalium 0/7 (0) 3/7 (43)
M. hyorhinis 0/7 (0) 5/8 (63)
doi:10.1371/journal.pone.0006872.t001
Figure 5. Molecular analysis of human BPH-1 xenograft tumors grown in nude male mice. Tumors generated by mycoplasma infection in
BPH-1 cells did not have a typical adenocarcinoma appearance, but a more squamoid appearance (H&E). In addition, uninfected BPH-1 cells from
passage 19 grown subcutaneously in nude mice were less angiogenic (CD34) and harbored more leukocytes (CD45) than did xenograft tumors from
BPH-1 cells infected with M. hyorhinis or M. genitalium. Only mycoplasma infected BPH-1 cells formed xenograft tumors. Expression of markers of
malignancy (CD44v9 and Ki-67) were revealed using immunohistochemistry. (10 micrometer scale bar =2 mm)
doi:10.1371/journal.pone.0006872.g005
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was utilized to reveal intratumoral vasculature. BPH-1 tumors
exposed to mycoplasma organisms demonstrated increased
vascularity compared to the small nodules produced by BPH-1
cells not exposed to mycoplasma (Figure 5). CD45 immunostain-
ing was employed to determine whether uninfected BPH-1
nodules were influenced by an accumulation of lymphoid cells.
Figure 5 clearly demonstrates that the bulk of the mycoplasma
infected tumors were devoid of lymphocytes. Conversely, subcu-
taneous masses generated from uninfected BPH-1 cells contained
more lymphocytes (Figure 5). In addition, the weak, focal CD44
variant 9 expression in the tissue of the uninfected BPH-1 nodules
confirms the lack of BPH-1 outgrowth in these nodules. In tumors
derived from BPH-1 infected with M. genitalium or M. hyorhinis,
there was strong membranous expression of this cell-surface tumor
cell marker (Figure 5). Ki-67, a marker of proliferation, was
negative in uninfected BPH-1 cell nuclei, but was positive in over
50% of the nuclei of cells infected with M. genitalium or M. hyorhinis
(Figure 5). Previously reported malignant transformation of BPH-1
cells by CAF or hormone treatments also resulted in a significant
increase in the proliferative index as revealed by an increase in Ki-
67 immunoreactivity [21].
Discussion
This is the first report describing the potential of mycoplasma
infection to lead to malignant transformation of benign human
prostate cells in cell culture and xenografts. Persistent infection of
BPH-1 for 19 weeks induced increased migration/invasion, the
acquisition of anchorage-independent growth, karyotypic entropy,
and finally, malignant transformation proven by the formation of
xenograft tumors in immune-compromised mice. BPH-1 cell
growth is normally anchorage-dependent and does not form
tumors in immunocompromised mice. Thus, we have developed a
model that may mimic aspects of the clinical progression of human
prostate cancer, and which can be applicable to the further study
of the link between infection and malignancy. While immortali-
zation or transformation of mammalian cells has been shown with
some other mycoplasma [22,23], to our knowledge, this is the first
time mammalian cell transformation has been achieved by
infection with either M. genitalium or M. hyorhinis.
Mycoplasma can cause a wide variety of diseases in mammals,
but most often they colonize respiratory and urogenital tracts
without immediate clinical significance [1,6]. Owing to their limited
biosynthetic capabilities, most mycoplasma are obligate parasites,
butby associating withmammaliancell membranesthey may evade
immune surveillance, and, therefore, they can persist chronically.
Prolonged infections with mycoplasma of even seemingly low
virulence could affect the phenotype of mammalian host cells [23–
25]. It is conceivable that chronic infection by certain mycoplasma
may increase host cell vulnerability to transformation events and
promote tumor growth of mammalian cells.
Of the two mycoplasma employed in this study, M. genitalium is
an established human pathogen already linked to urethritis [3–
5,26–28] and prostatitis [7,8,29]. M. hyorhinis is better known as a
porcine pathogen, but its status as the mycoplasma strain most
commonly infecting laboratory cell lines [1] implies that it can
thrive among human cells. The strongest link between M. hyorhinis
and human cancer was reported recently by Huang et al., who
used a monoclonal antibody against the unique M. hyorhinis–
specific protein p37 to detect mycoplasma infection in over 600
carcinoma tissues from a variety of organs. The study indicated
that up to 56% of gastric carcinoma and 55% of colon carcinoma
biopsies were positive for M. hyorhinis [30].
In our own work, we have previously demonstrated that treating
PC-3 and DU145 human prostate with recombinant M. hyorhinis
protein p37 results in increased proliferation, migration and
morphological changes, and significant perturbation in gene
expression profile [16,17]. We have recently elucidated the crystal
structure of the M. hyorhinis p37 protein and refined it to 1.6 A ˚
resolution. Mh-p37 has high homology to bacterial ABC
transporters, but we unexpectedly found that the protein binds
thiamine pyrophosphate, or vitamin B1 [31,32]. Investigations
into the role of Mh-p37 are ongoing, but understanding the
function of this protein may lead to the development of anti-
mycoplasmal agents, which given the findings of this study, may
have clinical utility in the field of prostate health.
The capacity of mycoplasma to induce malignancy in murine
cells has been previously demonstrated, however, murine cells are
known to be much more vulnerable than human cells to
transformation by a variety of stress-inducing events. Chronic
infection with M. fermentans or M. penetrans transformed C3H
mouse embryo cells. This mycoplasma-mediated oncogenic
process had a long latency and showed multistage progression.
After 18 weeks of infection, C3H cells revealed prominent
chromosomal changes, and were able to form tumors in animals
[23]. A study using 32D cells, a murine myeloid cell line, showed
that infection by M. fermentans or M. penetrans for only 4 to 5 weeks
induced malignant transformation of these cells. Transformed 32D
cells grew autonomously and quickly and ultimately formed
tumors when injected into nude mice [22].
Studies of prolonged mycoplasmal infection of human cells have
been rare. Zhang et al showed that Mycoplasma fermentans infection
of at least 6 weeks duration prolonged the survival of human
peripheral blood mononuclear cells (PBMCs) from healthy blood
donors in culture, and markedly enhanced the rate of EBV-
positive B lymphocytes to undergo immortalization, but not
transformation [33]. Without specific supplemental growth factors,
human PBMCs normally die rapidly in culture. To our
knowledge, the only other transformation of human cells by
mycoplasma infection used BEAS-2B, an immortalized human
bronchial epithelial cell line. These cells were immortalized by
infection with an adenovirus 12-SV40 virus hybrid (Ad12SV40)
and express the SV40 T antigen. BEAS-2B cells differentiate and
die when they become confluent in culture, and transform
spontaneously after 32 passages in subconfluent culture [34].
After prolonged infection (44 days) with Mycoplasma arginini, BEAS-
2B cells were observed to overcome contact inhibition and to gain
the capacity to grow when suspended in soft agar. After 12 weeks
of exposure to M. arginini, BEAS-2B cells were able to form tumors
in athymic nude mice.
The immortalized BPH-1 cell line was derived from primary
cultures of prostatic epithelial cells by introducing SV40T antigen
[20]. SV40T inactivates both p53 and Rb, thus negating two
important tumor suppressor pathways [34], however, as is the case
with BPH-1, many SV40T-expressing cells are not tumorigenic
[35,36]. The BPH-1 cell line is known to be susceptible to
malignant transformation when exposed to appropriate stimula-
tion. Wang et al. were able to induce formation of invasive BPH-1
tumors in the renal capsule of athymic mice through recombina-
tion with rat urogenital sinus mesenchyme (UGM) [37]. The same
research group has also shown that BPH-1 can be induced to form
xenograft tumors when combined with carcinoma associated
fibroblasts (CAFs) [21]. We show in this study that untreated BPH-
1 cells can survive in a murine host. It has been previously shown
that viable BPH-1 cells can be recovered from the graft site up to 1
year later [21], hence, in sum they meet the criteria of being
‘nontumorigenic’. BPH-1 cells can however be considered to be
Mycoplasma Transforms Prostate
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checkpoint mechanism, presumably attributable to the expression
of SV40T, and the accumulated chromosomal material increases
the probability of DNA damage accumulation. Further insult or
stress by an unknown mechanism may render them susceptible to
further genetic damage and to progression along a pathway to
malignancy. The mechanism by which such common genetic
changes could be induced by mycoplasmal infection environment
is at present unclear, but aneuploidy is one of the most obvious
differences between normal and cancer cells, and accordingly, has
been proposed to be a pivotal mechanism in cancer progression
[38]. Given the genomic instability associated with aneuploidy, it is
logical that cells have evolved mechanisms to prevent either the
proliferation or survival of aneuploid cells. Indeed, it has long been
observed that aneuploid cells often undergo a p53-dependent cell
cycle arrest in the G1 phase following cytokinesis failure [39]. As
described above, BPH1 cells have a compromised p53 function.
Our study revealed that while infection of BPH-1 cells was
transformative, the same mycoplasma could not influence the
phenotype of human CCL-123, a human fibroblast cell line that
has not been genetically manipulated in any way (data not shown).
CCL-123 cells seemed oblivious to the presence of mycoplasma
infection with either species; the cells exhibited no change in
culture, and entered senescence at passage 11–13 regardless of
mycoplasma infection status. This supports the notion that
mycoplasma are more likely to exacerbate host cell progression
to a malignant phenotype, rather than initiate cellular transfor-
mation. It is possible that mycoplasma can initiate the process over
extended periods of infection, but given the limited lifespan in
culture of ‘normal’ human cell lines such as CCL-123, this
hypothesis is difficult to test.
Prostate cancer, the most common visceral malignancy in
American men, will be diagnosed in approximately 186,320 men
and result in 28,660 deaths in 2006 [40]. Accordingly, epidemi-
ologic studies show that chronic inflammation is associated with an
increased risk of malignancy. The strongest associations revolve
around Epstein-Barr virus with lymphoma, hepatitis B with liver
cancer and Schistosomal infection with bladder cancer [41,42].
Recently, research has linked prostatitis, i.e., infection of the
prostate, to the development of prostate cancer. While the
prevalence of asymptomatic prostatitis is not known, symptomatic
prostatitis occurs in 9–10% of men between 40 and 79 years of
age. In most cases, no causative infectious organism can be
identified, so it is difficult to link symptomatic or asymptomatic
prostatitis with prostate cancer [7]. Mycoplasma organisms are
notoriously difficult to grow in standard culture condition and thus
are not easily detected by routine microbiologic techniques. The
fact that mycoplasma organisms have the capacity to be
internalized into human host cells creates another obstacle to
detecting mycoplasma [43]. To further investigate a linkage
between mycoplasma infection and prostate cancer, we are
currently performing quantitative screening of a large cohort of
benign and cancerous human prostate tissue samples for the
presence of M. genitalium and M. hyorhinis.
Based on three studies to date, viral involvement seems to be
associated with mycoplasma-induced human cell perturbation.
Mycoplasma have now been shown to immortalize or transform
EBV-positive PBMCs, SV40T expressing BEAS-2B cells, and now
SV40T-expressing BPH-1 cells. This implies that concomitant
infections with low-virulence viruses and mycoplasma may
synergistically induce accelerated transformation to malignancy.
Given the prevalence of nonpathogenic viral infections in humans,
it is entirely feasible that this double-infection could occur at
frequencies similar to those of cancer prevalence. It is interesting to
note that many Americans who took the Salk polio vaccine were
exposed to SV40. It has been estimated that 10–30 million of the
98 million people who received a polio shot during the period
1955–1963 actually received a vaccine that was contaminated with
SV40. In addition, about 10,000 volunteers who received an
experimental oral polio vaccine (OPV) between 1959–1961 may
have been exposed to SV40. Evidence to date indicates that after
1963, all vaccines on the U.S. market were free of SV40, but an
epidemiological study to investigate potential association of
individuals receiving SV40-contaminated vaccines with disease
in organs susceptible to chronic bacterial infection could be
revealing.
We have demonstrated the potential of M. genitalium and M.
hyorhinis to transform benign human prostate cells via a multi-stage
process over an extended period of exposure. Ultimately,
persistent mycoplasma infection over 19 weeks resulted in BPH-
1 cells gaining anchorage-independent growth in culture and the
capacity to form tumors in immunocompromised mice. Associated
with the acquired tumorigenicity was an accumulation of
chromosomal changes, typified by an increase in aneuploidy.
These observations suggest that M. genitalium and M. hyorhinis
infection can recapitulate genomic and phenotypic changes most
often associated with progression to malignancy. Further studies
into the mechanisms involved in this phenomenon are required,
but the idea that mycoplasma infection can exacerbate, or perhaps
even initiate human prostate malignancy may stimulate new
thinking on how we prevent, diagnose and treat prostate cancer.
Methods
Cell Lines and Culture
Human benign prostate cell line, BPH-1, and human benign
fibroblast cell line, CCL-123 were obtained from the American
Type Cell Culture (Manassas, VA). Cells were maintained in
RPMI media supplemented with 5% fetal bovine serum, 4.5 g/l
glucose, 4 mM L-glutamine, 100 units/ml penicillin and 100 mg/
ml streptomycin. All cells were incubated at 37uC in a humidified
atmosphere of 5% CO2 in air. All culture media were purchased
from Invitrogen (Carlsbad, CA).
Mycoplasma preparation and culture
Mycoplasma genitalium was a gift from Dr. Joel Baseman
(University of Texas Health Science Center, San Antonio, TX).
A stock solution of M. genitalium was prepared by growing the
microorganism to early log phase in SP4 broth, and stored frozen
at 280uC. Mycoplasma hyorhinis SK76, was a gift from Dr. Kim
Wise (University of Missouri, Columbia, MO). A stock solution of
M. hyorhinis was grown to early log phase in Frey’s broth, and
stored frozen at 280uC. Cultures for CFU determination of
inoculum were serially diluted 10-fold to 10
28 in appropriate
broth. Then 20 ml from each sample and its corresponding
dilutions (10
28) were plated on SP4 or Frey’s agar. Agar plates
were incubated at 37uCi n5 %C O 2; broth cultures were incubated
at 37uC in ambient air. Broth tubes were checked daily for a color
change, and the reciprocal of the last dilution to show growth was
deemed the color-changing unit (CCU). In order to confirm
growth of M. genitalium and M. hyorhinis, color-changing units
(CCU), which provide a relative indication of the amount of
microbes present, were determined. Samples were serially diluted
tenfold in SP4 or Frey’s broth in duplicate. Broth tubes were
checked daily for a color change, and the CCU was recorded as
the reciprocal of the last dilution to show growth at 21 days. Agar
cultures were incubated for at least 5 days before colonies were
counted. Human benign prostate BPH-1, and human benign
Mycoplasma Transforms Prostate
PLoS ONE | www.plosone.org 7 September 2009 | Volume 4 | Issue 9 | e6872fibroblast CCL-123 cells, previously tested negative by PCR for
mycoplasma contamination (PCR Mycoplasma Detction Ste from
Takara, Japan), were grown in complete RPMI with 10% fetal
bovine serum (FBS), without antibiotics. Cell densities in each flask
were reduced to approximately 0.05610
5 cells per flask by
passaging without trypsin (Versene) on a weekly basis, when cell
density approached confluence. Cell cultures typically grew from a
density of 10
4 cells per ml at day 1 to 10
6 cells per ml at day 7.
Freshly seeded monolayer cultures of BPH-1 and CCL-123 cells
were prepared in quadruplicate, with cell density of 0.5610
5 per
25 cm
2 flask. One flask of each cell line was inoculated with
0.01 ml sterile SP4, 4610
3 CFU of M. genitalium (0.01 ml), 0.01 ml
of sterile Frey’s or 4610
3 CFU of M. hyorhinis (0.01 ml). After
24 hours, cell culture medium from each flask was exchanged with
fresh sterile complete RPMI/FBS. Subsequent medium changes
were performed every 72 or 96 hours until cell harvest. M.
genitalium, and M. hyorhinis infection of inoculated cells was
confirmed by PCR. Briefly, the following primers were used for
PCR: Mh sense primer 59- ACACCATGGGAGCTGGTAAT-39
and antisense primer 59- CTTCTCGACTTTCAGA-39 and Mg
sense primer 59- AGTTGATGAAACCTTAACCCCTTGG-39
and antisense primer 59- CCGTTGAGGGGTTTTCCA-
TTTTTGC-39. The amplification conditions of Mg PCR
consisted of initial denaturation at 95’C for 10 min followed by
32 cycles of denaturation at 95’C for 30 sec, annealing at 60’C for
1 min and elongation at 72’C for 1 min. The amplification
conditions of Mh PCR consisted of initial denaturation at 94’C for
1 min followed by 35 cycles of denaturation at 94’C for 30 sec,
annealing at 55’C for 2 min and elongation at 72’C for 1 min.
BPH-1 and CCL-123 cultures at 7 and 19 weeks post infection
were assessed for changes associated with malignant transforma-
tion. Unfortunately by week 11, CCL-123 cell viability was
markedly reduced and by week 13 the reduction in cell number
precluded any further assessment of these cultures in vitro or in vivo.
The growth rate of immortalized BPH-1 cells in culture was
unchanged over the 19 weeks of the study. All in vitro and in vivo
analyses were performed on parallel cultures (untreated or infected
with M. hyorhinis, M. genitalium) originating from the same stock,
and were analyzed at the same passage.
In vitro cell migration and invasion assays. Migration
assays were performed in six-well two-tier invasion chambers
(Collaborative Biomedical Products, Bedford, MA, USA), using a
protocol similar to that used successfully by others [44].
Polycarbonate membranes were coated with 4 mg/ml growth
factor reduced Matrigel (BD Biosciences, San Jose, CA) as
described for invasion assays, control inserts (migration only)
contained no coating. Uninfected and mycoplasmal infected BPH-
1 and CCL-123 cells were added to each insert at a density of
100,000 cells/ml/well in RPMI media. The lower chamber
contained RPMI media with 10% FBS as chemoattractant. After
incubation in a humidified incubator with 5% CO2 at 37uC for
24 hours, the cells on the top of the polycarbonate membrane
were removed. The cells attached to the bottom of the membrane
were fixed in 100% methanol, stained with LeukoStat Staining kit
(Fisher), and counted microscopically. Each assay was performed
in triplicate. Comparisons between group means were assessed
with the paired Student t-test.
Anchorage-Independent Cell Growth
Anchorage-independent cell growth was assayed by the capacity
of cells to form colonies in soft agar. The technique of examining
cloning efficiency of various transformed cells in soft agar was
previously described in detail [45]. To assess the cloning efficiency,
1610
4 uninfected or mycoplasma infected BPH-1 or CCL-123
cells were plated on Petri dishes in 0.3% agar/media. The
presence or absence of colonies was documented.
Spectral Karyotyping (SKY)
At week 19, only BPH-1 cells were analyzed cytogenetically by
Spectral Karyotyping (SKY). Karyotypic data were obtained from
5–10 fully analyzed metaphase cells per cell line. Metaphase
spreads were prepared using standard cytogenetic methods, and
slides were aged overnight at room temperature. SKY hybridiza-
tion and image capture/analysis were performed according to the
manufacturer’s instructions (Applied Spectral Imaging, Carlsbad,
CA) as previously described [19,49]. Probes were created by
polymerase chain reaction (PCR) amplification using degenerate
primers and incorporation of three fluorochromes and two
haptens (biotin and digoxigenin) using purified single-chromosome
templates. Haptens were detected indirectly using Cy5-conjugated
avidin and Cy5.5-conjugated antimouse IgG (Rockland, Gilberts-
ville, PA). Slides were counterstained with DAPI and mounted
with Prolong Antifade solution (Molecular Probes, Eugene, OR).
Spectral imaging was achieved using a SpectraCube system
(Applied Spectral Imaging) viewed through a 60x objective
illuminated by a xenon lamp. Chromosomes were classified with
SkyView software (Applied Spectral Imaging). DAPI banding was
captured separately and inverted for alignment with spectral
representations using SkyView software.
Tumorigenicity in nude mice
BPH-1 cells were further studied in an in vivo setting. Uninfected
and mycoplasma infected BPH-1 cells (1610
6 in 1 mg/ml
Matrigel, Becton Dickinson Labware, Bedford, MA) from passages
7 and 19 were injected subcutaneously into the right flanks of 5- to
6-week-old nude male mice (Harlan-Sprague-Dawley, Indianapo-
lis, IN). Seven to eight mice were in each group. The mice were
carefully followed for 15 weeks for tumor formation. At 15 weeks,
mice were sacrificed. Full necropsies were performed and
histopathology of tumors was documented.
Immunohistochemical Analysis
Subcutaneous tumors or nodules at the site previously injected
with BPH-1 cells were assessed by two independent pathologists
(R.W.A., K.A.I.) using histopathologic examination. In addition, a
panel of immunohistochemical stains was performed to a) identify
areas of angiogenesis in tumors, b) identify lymphoid infiltrate
possibly mimicking a tumor, c) identify tumor associated antigens,
and d) estimate the cellular proliferative rate in tumors.
Angiogenesis and lymphoid infiltrate were assessed by immuno-
staining utilizing antibodies to CD 34 and CD 45, respectively.
CD44v9 served as a marker for prostate malignancy [47,48].
Frozen tumor sections (8–10 mm thick) were mounted on
Superfrost Plus slides (Fisher Scientific, Hampton, NH), fixed in
cold acetone for 5 min, and then incubated overnight at 4uC with
monoclonal rat anti-mouse CD34 antibody (RAM 34 clone) (1:100
dilution; BD PharMingen, San Diego, CA), monoclonal rat anti-
mouse CD45 antibody (Ly 5 clone) (1:25 dilution; BD PharMin-
gen, San Diego, CA), or monoclonal anti-CD44v9 antibody (HB-
258 hybridoma supernatant, ATCC). In addition, 5 mm thick
paraffin sections of xenograft tissues were placed on poly-L-lysine-
coated slides. The slides were deparaffinized and treated with
0.3% hydrogen peroxide and deionized water to block endogenous
peroxidase activity. The sections were incubated overnight with
Ki-67 antibody (dilution 1:100; Dako, Carpinteria, CA), a marker
for cellular proliferation. Specimens were washed 4 times with PBS
after antibody incubation, treated with the appropriate dilution of
a biotinylated anti-rabbit IgG, anti-mouse IgG, or anti-rat IgG,
Mycoplasma Transforms Prostate
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slides were counterstained with hematoxylin, dehydrated, and
mounted on slides with Permount.
Statistical Analysis
Migration and invasion assays were analyzed by student t test
(paired) and tumor incidence was analyzed by the x
2 test. A value
of P,0.05 was considered significant.
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